Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4755734 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL1272496 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL4756817 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL50290 | 1.00 | — | — | |
| SCHEMBL231055 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL1881247 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL337457 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL50313 | 1.00 | — | — | |
| SCHEMBL3595771 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL1875895 | 1.00 | LMNA (0.44) | LMNAALDH1A1TSHRHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115348867-B | Topically applicable lysate (Ly) of plant guayule dedifferentiated cells for eliminating or reducing skin inflammation | 化工产品开发公司SEPPIC | 2024-05-17 | — | — | CN | disclosed |
| EP-4358932-A1 | THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2024-05-01 | — | — | EP | disclosed |
| EP-4358933-A1 | COPOLYMER THICKENING COMPOSITION COMPRISING AT LEAST ONE OIL AND AT LEAST ONE POLY(ITACONATE) FOR THICKENING POLAR OR APOLAR OILS | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2024-05-01 | — | — | EP | disclosed |
| EP-4349418-A2 | TOPICALLY ADMINISTRABLE HELICHRYSUM STOECHAS PLANT DEDIFFERENTIATED CELL LYSATE (LY) FOR REMOVING OR REDUCING SKIN INFLAMMATION | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2024-04-10 | — | — | EP | disclosed |
| EP-4106784-B1 | TOPICALLY ADMINISTRABLE LYSATE (LY) OF DEDIFFERENTIATED CELLS OF THE PLANT HELICHRYSUM STOECHAS FOR ELIMINATING OR REDUCING INFLAMMATION OF THE SKIN | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2024-04-03 | — | — | EP | disclosed |
| CN-113318012-B | Composition for topical application in the form of a gel containing mineralized water | 化工产品开发公司SEPPIC | 2024-03-12 | — | — | CN | disclosed |
| EP-4329730-A2 | A SPECIFIC COMBINATION OF LIPIDS AND METHODS AND USES RELATED THERETO | Helsingin Yliopisto (FI) | 2024-03-06 | — | — | EP | disclosed |
| EP-4331686-A2 | TEMPERATURE-STABLE ALKANE AND ESTER COMPOSITIONS, THEIR USE AS EMOLLIENT AGENTS, AND EMULSIONS COMPRISING THEM | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2024-03-06 | — | — | EP | disclosed |
| US-20240033207-A1 | TOPICALLY ADMINISTRABLE LYSATE (LY) OF DEDIFFERENTIATED CELLS OF THE PLANT HELICHRYSUM STOECHAS FOR ELIMINATING OR REDUCING INFLAMMATION OF THE SKIN | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2024-02-01 | — | — | US | disclosed |
| CN-117479922-A | Thickening composition for thickening polar or nonpolar oils | 化工产品开发公司SEPPIC | 2024-01-30 | — | — | CN | disclosed |
| EP-0740651-A1 | AMINE DERIVATIVE AND DETERGENT COMPOSITION CONTAINING THE SAME | Kao Corporation (JP) | 1996-11-06 | — | — | EP | disclosed |
| WO-1995016664-A1 | AMINE DERIVATIVE AND DETERGENT COMPOSITION CONTAINING THE SAME | KAO CORPORATION (JP) | 1995-06-22 | — | — | WO | disclosed |
| US-5409705-A | Phosphobetaine and detergent and cosmetic containing the same | KAO CORPORATION (JP) | 1995-04-25 | — | — | US | disclosed |
| EP-0530442-A1 | Process for producing a hydroxy-substituted poly (phenylene ether) resin | MITSUBISHI CHEMICAL CORPORATION (JP) | 1993-03-10 | — | — | EP | disclosed |
| EP-0514588-A2 | Novel phosphobetaine and detergent and cosmetic containing the same | Kao Corporation (JP) | 1991-11-25 | — | — | EP | disclosed |
| US-4525294-A | Amino acid mixtures, their alkali metal salts and process for preparing same | EXXON RESEARCH AND ENGINEERING CO. (US) | 1985-06-25 | — | — | US | disclosed |
| EP-0109354-A1 | Biocidally active mixture | CIBA-GEIGY AG (CH) | 1984-05-23 | — | — | EP | disclosed |
| EP-0079767-A2 | Amino acids and a process for preparing same | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-05-25 | — | — | EP | disclosed |
| US-4351962-A | Process for the preparation of hydroxy benzene carboxaldehydes | RHONE POULENC INC. (US) | 1982-09-28 | — | — | US | disclosed |
| US-4190601-A | Production of tertiary amines by reductive alkylation | UNION CARBIDE CORPORATION (US) | 1980-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240033207-A1 | TOPICALLY ADMINISTRABLE LYSATE (LY) OF DEDIFFERENTIATED CELLS OF THE PLANT HELICHRYSUM STOECHAS FOR ELIMINATING OR REDUCING INFLAMMATION OF THE SKIN | CUTA, MMP8, S100A8 | LMNA 647/4885ALDH1A1 4173/4885TSHR 2936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.